CD34+ UCB cells have been successfully cultured and expanded in pre-clinical studies81-83 and in clinical studies in adult hematological malignancies,84 but there are no clinical trials testing the use of an expanded CD34+ product in neonates. This evidence concerns the gene CD34 and hematologic disorder.